HANNA AGARD: Open Payments
NPI 1770832776 · ALTAMONTE SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 60 payments from 13 companies in 2025. Trend: 2023 $1,595 · 2024 $1,225 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $514 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $218 |
| Janssen Biotech, Inc. | 9 | $130 |
| Celltrion USA Inc. | 6 | $124 |
| Janssen Scientific Affairs, LLC | 1 | $71 |
| GENZYME CORPORATION | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Enterra Medical, Inc. | 2 | $42 |
| VIVUS LLC | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
Products named: TREMFYA, ENTYVIO, RINVOQ, SKYRIZI, VEGZELMA, DUPIXENT, LINZESS, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
